Kanova Pharma

Pharmaceutical API manufacturing, trading, and chemical services in India.

About Kanova Pharma

Kanova Pharma is a Chemicals & Materials company. Pharmaceutical API manufacturing, trading, and chemical services in India. It operates in the Chemicals & Materials and Healthcare sectors. The company has 1 employees. Its Indian entity Kanova Pharma Private Limited reported revenue of β‚Ή44.10 Cr. Kanova Pharma offers products and services including API Products and Pharmaceutical Intermediates. Its focus areas include Chemicals, Industrial Supplies, Chemical Trading and Solvents and Intermediates.

Company details

Kanova Pharma is identified as a competent entity in the APIs research and manufacturing sector, where pharmaceutical raw materials, intermediates, and chemicals are traded and produced. Strong supplier networks in Asian countries are utilized to offer a broad range of products and services in industrial and commercial markets. Quality products are delivered with a focus on customer satisfaction, supported by robust RD capabilities and manufacturing facilities in Hyderabad, Telangana, India. Continuous market updates and on-time deliveries are emphasized to meet client expectations across therapeutic areas.

  • Employees 1
  • Sectors
    Chemicals & Materials
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website kanovapharma.com
  • Legal Name Kanova Pharma Pvt Ltd
  • Date of Incorporation 18 Apr, 2022
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Indian entity revenue
    ₹44.10 Cr

    FY 2024 · +164% YoY

  • Indian entity net profit
    ₹89.9 Lakh

    FY 2024 · 2% margin

  • Indian entity EBITDA
    ₹1.28 Cr

    FY 2024 · 3% margin

  • Employee Count
    1

Products & Services of Kanova Pharma

Kanova Pharma offers a comprehensive portfolio of products and services, including API Products and Pharmaceutical Intermediates.

API Products
Pharmaceutical Products

APIs are manufactured and traded by Kanova Pharma for use in drug production

Pharmaceutical Intermediates
Chemical Intermediates

Intermediates are supplied by Kanova Pharma for the development of various pharmaceutical compounds

Board of directors of Kanova Pharma Private Limited (Kanova Pharma)

Kanova Pharma Private Limited is the primary company behind Kanova Pharma. The board of Kanova Pharma Private Limited currently have 2 directors; the longest-serving is Sai Vivek Konishetty, appointed in 2023. 6 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sai Vivek Konishetty
DIN 10304313
Director05 Sep 20233 yrs 2 moKanova Pharma Private Limited
Chimakurthi Bhagyalakshmi
DIN 10478939
Director09 Jul 20242 yrs 4 moKanova Pharma Private Limited

Financials of Kanova Pharma

Figures of Kanova Pharma Private Limited, the primary company behind Kanova Pharma, for FY 2024. Revenue was ₹44.10 Cr (+164% year on year). Net profit was ₹89.9 Lakh (2% margin). EBITDA was ₹1.28 Cr (3% margin).

  • ₹44.10 CrRevenue · FY 2024 · +164% YoY
  • ₹89.9 LakhNet profit · 2% margin
  • ₹1.28 CrEBITDA · 3% margin
  • ₹2.50 CrPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Kanova Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Kanova Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Kanova Pharma

Kanova Pharma has 1 employees.

The primary company behind Kanova Pharma, Kanova Pharma Private Limited, reported revenue of β‚Ή44.10 Cr for FY 2024, up 164% year on year.

Kanova Pharma is identified as a competent entity in the APIs research and manufacturing sector, where pharmaceutical raw materials, intermediates, and chemicals are traded and produced. Strong supplier networks in Asian countries are utilized to offer a broad range of products and services in industrial and commercial markets. Quality products are delivered with a focus on customer satisfaction, supported by robust RD capabilities and manufacturing facilities in Hyderabad, Telangana, India. Continuous market updates and on-time deliveries are emphasized to meet client expectations across therapeutic areas.

Kanova Pharma offers API Products and Pharmaceutical Intermediates.

Kanova Pharma operates through Kanova Pharma Private Limited.

The legal entities of Kanova Pharma currently have 2 directors, including Sai Vivek Konishetty, Chimakurthi Bhagyalakshmi.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available